Mini-Metrxics: a single-centre, randomized, double-blind, parallel-group, placebo-controlled, clinical trial of CMI X-11S in higher risk geriatric patients undergoing open-heart surgical procedures (OHSP)
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2007
At a glance
- Drugs CMI X 11S (Primary)
- Indications Coronary disorders
- Focus Therapeutic Use
- Acronyms Mini-METR*ICS
- Sponsors Valens Pharma
- 11 Dec 2007 The enrolment midpoint has been reached, with 40 patients currently enrolled.
- 13 Aug 2007 New trial record.